Bill Commons

NY A 9359

in committee

Increases the maximum amount of individual awards for the physician loan repayment program and physician practice support program

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 9359 pass?

Not yet. NY A 9359 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH

What is NY A 9359 about?

Increases the maximum amount of individual awards for the physician loan repayment program and physician practice support program to encourage physicians to practice in underserved areas.

Who sponsors NY A 9359?

Marianne Buttenschon is the primary sponsor of NY A 9359, joined by 1 cosponsor.

Description

Increases the maximum amount of individual awards for the physician loan repayment program and physician practice support program to encourage physicians to practice in underserved areas.

Introduced
Latest action
2026-01-07 — REFERRED TO HEALTH
Bill type
bill
Last updated

Sponsors

  • Marianne Buttenschonprimary
  • Phil Steckcosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-12-19

    REFERRED TO HEALTH

    referral-committee

  2. 2026-01-07

    REFERRED TO HEALTH

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

  • Prior session: S 5662not in this corpus
  • Prior session: S 4267not in this corpus
  • Prior session: S 4227not in this corpus
  • Companion bill: S 5071

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 9359. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.